The United States of America, as Represented by the Secretary of Agriculture;The University of Connecticut
发明人:
Manuel V. Borca,Lauren G. Holinka-Patterson,Vivian K. O'Donnell,Guillermo S. Risatti,Douglas Gladu,Vivian K. ODonnell
申请号：
US14537248
公开号：
US09528094B2
申请日:
2014.11.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
African swine fever virus (ASFV) is the etiological agent of a contagious and often lethal viral disease of domestic pigs. Control of ASF has been hampered by the unavailability of vaccines. Experimental vaccines have been derived from naturally occurring, cell culture-adapted, or genetically modified live attenuated ASFVs； however, these vaccines are only successful when protecting against homologous viruses. Among viral genes reported to be involved in virulence are components of the multi gene family (MGF). Here we report the construction of a recombinant ΔMGF virus derived from the highly virulent ASFV Georgia 2007 (ASFV-G) isolate. In vivo, ASFV-G ΔMGF administered intramuscularly (IM) to swine at either 102 or 104 HAD50 are completely attenuated； the inoculated animals are completely asymptomatic. Animals infected with 102 or 104 HAD50 of ASFV-G ΔMGF are protected against the presentation of clinical disease when challenged at 28 days post infection with the virulent parental strain Georgia 2007.
